Serotonin- norepinephrine reuptake inhibitors (SNRI) increase the risk for hypertensive disorders of pregnancy (HDP) by 80% ...
Switching from an SSRI to an SNRI typically involves gradually tapering off the SSRI under a doctor’s guidance and starting the SNRI at a low dose. Switching from a selective serotonin reuptake ...
Atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI), may improve outcomes for patients with both attention-deficit/hyperactivity disorder (ADHD) and ...
LAS VEGAS, NV — Vincent Brett, MS, PharmD, of Janssen Scientific Affairs, Raritan, NJ, and colleagues presented a post-hoc analysis of pooled safety data at PAINWeek 2012, and found that adding ...
Results showed that discontinuation of any SNRI was associated with withdrawal symptoms, with the highest prevalence linked to venlafaxine and desvenlafaxine. Serotonin-noradrenaline reuptake ...
Desvenlafaxine, the major active metabolite of venlafaxine (Effexor XR, also from Wyeth), is a potent and selective SNRI. The increase in the effects of these neurotransmitters in the central nervous ...
The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs ...
(Montreal, June 27, 2002)—People with social anxiety disorder (SAD), also known as social phobia, significantly reduced their fear, anxiety and related symptoms in four or six weeks of treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results